Literature DB >> 23991827

PPARδ activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference.

Yuan Z Feng1, Nataša Nikolić, Siril S Bakke, Mark V Boekschoten, Sander Kersten, Eili T Kase, Arild C Rustan, G Hege Thoresen.   

Abstract

The role of peroxisome proliferator-activated receptor δ (PPARδ) activation on global gene expression and mitochondrial fuel utilization were investigated in human myotubes. Only 21 genes were up-regulated and 3 genes were down-regulated after activation by the PPARδ agonist GW501516. Pathway analysis showed up-regulated mitochondrial fatty acid oxidation, TCA cycle and cholesterol biosynthesis. GW501516 increased oleic acid oxidation and mitochondrial oxidative capacity by 2-fold. Glucose uptake and oxidation were reduced, but total substrate oxidation was not affected, indicating a fuel switch from glucose to fatty acid. Cholesterol biosynthesis was increased, but lipid biosynthesis and mitochondrial content were not affected. This study confirmed that the principal effect of PPARδ activation was to increase mitochondrial fatty acid oxidative capacity. Our results further suggest that PPARδ activation reduced glucose utilization through a switch in mitochondrial substrate preference by up-regulating pyruvate dehydrogenase kinase isozyme 4 and genes involved in lipid metabolism and fatty acid oxidation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23991827     DOI: 10.3109/13813455.2013.829105

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  8 in total

1.  Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes.

Authors:  Stephanie Chanon; Christine Durand; Aurelie Vieille-Marchiset; Maud Robert; Charna Dibner; Chantal Simon; Etienne Lefai
Journal:  J Vis Exp       Date:  2017-06-25       Impact factor: 1.355

2.  Single- and multiple-dose safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of ASP0367, or bocidelpar sulfate, a novel modulator of peroxisome proliferator-activated receptor delta in healthy adults: Results from a phase 1 study.

Authors:  Mototsugu Ito; Sitra Tauscher-Wisniewski; Ronald A Smulders; Tomasz Wojtkowski; Akihiro Yamada; Akira Koibuchi; Tolga Uz; Gerard J Marek; Ronald D Goldwater
Journal:  Muscle Nerve       Date:  2021-10-28       Impact factor: 3.852

3.  Exercise in vivo marks human myotubes in vitro: Training-induced increase in lipid metabolism.

Authors:  Jenny Lund; Arild C Rustan; Nils G Løvsletten; Jonathan M Mudry; Torgrim M Langleite; Yuan Z Feng; Camilla Stensrud; Mari G Brubak; Christian A Drevon; Kåre I Birkeland; Kristoffer J Kolnes; Egil I Johansen; Daniel S Tangen; Hans K Stadheim; Hanne L Gulseth; Anna Krook; Eili T Kase; Jørgen Jensen; G Hege Thoresen
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

4.  Chronic treatment with terbutaline increases glucose and oleic acid oxidation and protein synthesis in cultured human myotubes.

Authors:  Christine Skagen; Tuula A Nyman; Xiao-Rong Peng; Gavin O'Mahony; Eili Tranheim Kase; Arild Chr Rustan; G Hege Thoresen
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-06-11

5.  The effect of toll-like receptor ligands on energy metabolism and myokine expression and secretion in cultured human skeletal muscle cells.

Authors:  Ragna H Tingstad; Frode Norheim; Fred Haugen; Yuan Z Feng; Hege S Tunsjø; G Hege Thoresen; Arild C Rustan; Colin Charnock; Vigdis Aas
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379

6.  The application of transcriptomic data in the authentication of beef derived from contrasting production systems.

Authors:  Torres Sweeney; Alex Lejeune; Aidan P Moloney; Frank J Monahan; Paul Mc Gettigan; Gerard Downey; Stephen D E Park; Marion T Ryan
Journal:  BMC Genomics       Date:  2016-09-21       Impact factor: 3.969

Review 7.  An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors.

Authors:  Wendy Wen Ting Phua; Melissa Xin Yu Wong; Zehuan Liao; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2018-05-10       Impact factor: 5.923

Review 8.  Targeting acute kidney injury in COVID-19.

Authors:  John A Kellum; J W Olivier van Till; George Mulligan
Journal:  Nephrol Dial Transplant       Date:  2020-10-01       Impact factor: 5.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.